Live
BrukerBruker showcases expanded microbiology diagnostics portfolio - Investing.comBrukerBruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026 - 巴士的報Endpoints NewsADC Therapeutics' confirmatory data for Zynlonta muddied by death ratesEli LillyEli Lilly continues genetic medicine push with $1.9bn Ascidian partnership - Pharmaceutical TechnologyEli LillyEli Lilly forms billion-dollar genetic kidney disease partnership with US biotech Ascidian Therapeutics - medwatch.comFierceBiotechAlnylam pens $2B deal with Inceptive to transform siRNA design with AI pioneerSamsung BiologicsGlobal firms tighten hold on Korea’s biopharma supply chain - KED GlobalEndpoints NewsADC biotech Ona Therapeutics secures $86.6M in Series B raiseBioPharma DiveA Spanish biotech banks $87M to make differentiated ADCsLonza NewsLonza advances integrated DNA‑to‑IND programmes with acceleration, derisking and innovation - Manufacturing ChemistPfizerModerna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge - NAI500ModernaHeated LNP litigation puts Moderna and Acuitas in the spotlight - Life Sciences Intellectual Property Review
Dieser Artikel ist im Archiv nicht verfügbar.